Health News on One News Page [United States]

Reported by Reuters
(Reuters) - Sarepta Therapeutics' shares jumped 60 percent on Tuesday after promising results from a gene therapy study positioned the specialty drugmaker as a potential leader in the market for Duchenne muscular dystrophy (DMD) treatments. »more

Health Videos

Rachel Maddow Tears Up While Reporting Immigrant Family Separation

Fake meds draw concerns from online pharmacy users

WI doctors work to cure muscular dystrophy

New York Doctors Save Boy, 9, From Honduras With Serious Heart Defect

US activists interrupt Secretary Nielsen's dinner at a Mexican restaurant

New Yorkers protest family separations at U.S. border

CANADA

Canada Senate Approves Recreational Use of Marijuana

Canada's upper house of parliament on Tuesday approved a revised bill to legalize recreational marijuana, setting the stage for the country to become the first Group of Seven nation to legalize cannabis.The Senate voted 52-29 in favor of the revised bill from the elected...

Newsmax 5 hours ago

TRUMP ADMINISTRATION

Trump administration puts skimpy health insurance plans in place

NEW YORK (Reuters) - The Trump administration on Tuesday issued a finalized rule that will enable millions of Americans to buy skimpy health insurance plans that do not comply with key Obamacare coverage requirements, marking its latest effort to chip away at the healthcare law.

Reuters 15 hours ago

BABIES

Fathers' Antidepressant Use Doesn't Worsen Babies' Health Risks

Fathers' use of antidepressant medications around the time mothers become pregnant does not increase babies' risk of preterm birth, birth defects, autism or intellectual disability, according to a study in the BMJ. Study leader Sven Sandin of the Icahn School of Medicine at...

Newsmax 7 hours ago

HONDURAS